Granulocyte Colony-stimulating Factor Reduces Mortality by Suppressing Ventricular Arrhythmias in Acute Phase of Myocardial Infarction in Rats


Autoria(s): BALDO, Marcelo P.; DAVEL, Ana Paula C.; NICOLETTI-CARVALHO, Jose E.; BORDIN, Silvana; ROSSONI, Luciana V.; MILL, Jose G.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

20/10/2012

20/10/2012

2008

Resumo

Our aim was to evaluate the effects of granulocyte colony-stimulating factor (G-CSF) on early cardiac arrhythmias after myocardial infarction (MI) and the impact on survival. Male Wistar rats received repeated doses of 50 mu g/kg G-CSF (MI-GCSF group) or vehicle (MI group) at 7, 3, and 1 days before surgery. MI was induced by permanent occlusion of left corollary artery. The electrocardiogram was obtained before occlusion and then for 30 minutes after surgery. Events and duration of ventricular arrhythmias were analyzed. The levels of connexin43 (Cx43) were measured by Western blot immediately before MI production. Survival was significantly increased in MI-GCSF pretreated group (74% versus 52.0% MI. P < 0.05). G-CSF pretreatment also significantly reduced the ventricular premature beats when compared with the untreated-MI group (201 +/- 47 versus 679 +/- 117, P < 0.05). The number and the duration of ventricular tachycardia were smaller in the MI-G-CSF group, as well as the number of ventricular fibrillation episodes (10% versus 69% in NIL P < 0.05). Cx43 levels were significantly increased by G-CSF treatment (1.27 +/- 0.13 versus 0.86 +/- 0.11; P < 0.05). The MI size 24 hours after occlusion was reduced by G-CSF pretreatment (36 +/- 3% versus 44 +/- 2% of left ventricle in MI group; P < 0.05). The increase of Cx43 expression in the heart may explain the reduced incidence in ventricular arrhythmias in the early phases after coronary artery occlusion in rats, thus increasing survival after MI.

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Fundacao de Amparo a Pesquisa do Espirito Santo - Pronex (FAPES)

Fundacao de Amparo a Pesquisa do Espirito Santo - Pronex (FAPES)

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)

Identificador

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, v.52, n.4, p.375-380, 2008

0160-2446

http://producao.usp.br/handle/BDPI/27933

10.1097/FJC.0b013e31818a2bb0

http://dx.doi.org/10.1097/FJC.0b013e31818a2bb0

Idioma(s)

eng

Publicador

LIPPINCOTT WILLIAMS & WILKINS

Relação

Journal of Cardiovascular Pharmacology

Direitos

restrictedAccess

Copyright LIPPINCOTT WILLIAMS & WILKINS

Palavras-Chave #G-CSF #myocardial infarction #survival #ventricular arrhythmias #HEMATOPOIETIC STEM-CELLS #ANESTHETIZED RATS #G-CSF #ISCHEMIA #HEART #REPERFUSION #CONNEXIN43 #PATHWAY #DEATH #ARRHYTHMOGENESIS #Cardiac & Cardiovascular Systems #Pharmacology & Pharmacy
Tipo

article

original article

publishedVersion